US Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals
US Investment Grade Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-10-26: 10Y at 5.79%, fitted curve 1M–75Y (4.69%–6.21%), 766 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.69% | — |
| 3M | 4.71% | 4.72% |
| 6M | 4.75% | 4.90% |
| 9M | 4.79% | 5.00% |
| 12M | 4.84% | 5.00% |
| 18M | 4.97% | 5.31% |
| 2Y | 5.07% | 5.47% |
| 3Y | 5.23% | 5.63% |
| 4Y | 5.35% | 5.85% |
| 5Y | 5.44% | 5.92% |
| 6Y | 5.50% | 6.00% |
| 7Y | 5.57% | 6.18% |
| 8Y | 5.65% | 6.41% |
| 9Y | 5.72% | 6.59% |
| 10Y | 5.79% | 6.71% |
| 15Y | 6.02% | 6.88% |
| 20Y | 6.13% | 6.89% |
| 25Y | 6.18% | 6.76% |
| 30Y | 6.20% | 6.62% |
| 40Y | 6.21% | 6.47% |
| 75Y | 6.21% | 6.33% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 5.07% and the 10-year 5.79%, a 10Y−2Y spread of +71 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 5.07% | 5.17% | 4.67% | 4.69% | 4.56% | 4.46% | 4.38% |
| 10Y | 5.79% | 5.91% | 5.41% | 5.44% | 5.11% | 5.17% | 5.21% |
| 10Y − 2Y | +71 bp | +74 bp | +74 bp | +76 bp | +55 bp | +71 bp | +83 bp |
Yields by rating group
The same curve split by credit quality: 808 rated bonds across 2 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.33%, A+ to BBB- 5.69%.
Bonds in this curve
A selection of 30 of the 808 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Abbott | 4.67% | 2026-11-30 | 3.75% | US002824BF69 |
| Thermo Fisher | 4.89% | 2026-12-05 | 5.00% | US883556CZ38 |
| ELI Lilly | 4.39% | 2027-02-09 | 4.50% | US532457CJ56 |
| Amgen INC | 4.95% | 2027-02-21 | 2.20% | US031162CT53 |
| GSK Capital INC | 4.39% | 2027-03-12 | 4.32% | US377373AM70 |
| CSL Finance | 5.11% | 2027-04-27 | 3.85% | USG2584CAA48 |
| Astrazeneca | 4.57% | 2027-06-12 | 3.12% | US046353AN82 |
| Merck | 4.77% | 2027-06-10 | 1.70% | US58933YBC84 |
| Zoetis | 4.94% | 2027-09-12 | 3.00% | US98978VAL71 |
| Merck | 4.62% | 2027-09-15 | 3.85% | US58933YBP97 |
| Abbott | 4.78% | 2028-01-30 | 1.15% | US002824BP42 |
| ELI Lilly | 4.62% | 2028-02-12 | 4.55% | US532457CU02 |
| Roche Holding | 4.90% | 2028-09-17 | 3.62% | USU75000BP05 |
| CSL Finance | 5.32% | 2029-04-27 | 4.05% | USG2584CAB21 |
| Johnson & Johnson | 4.74% | 2029-06-01 | 4.80% | US478160CU63 |
| Teva | 5.43% | 2029-05-09 | 5.12% | US88167AAQ40 |
| Biogen | 5.38% | 2030-05-01 | 2.25% | US09062XAH61 |
| Roche Holding | 5.23% | 2030-11-13 | 5.49% | USU75000CG96 |
| Terumo Corporation | 5.48% | 2031-04-28 | 4.49% | XS3327684414 |
| Mckesson | 5.42% | 2032-05-30 | 4.95% | US581557BX22 |
| Bayer AG | 6.02% | 2033-07-20 | 5.38% | USU07264AR24 |
| Bayer AG | 6.01% | 2034-07-15 | 4.20% | US07274NAZ69 |
| Teva | 5.96% | 2036-02-01 | 6.15% | US88163VAD10 |
| HCA INC | 6.34% | 2036-07-15 | 7.75% | US19767QAS49 |
| Amgen INC | 6.00% | 2041-08-15 | 2.80% | US031162DA53 |
| Celgene | 6.48% | 2044-05-15 | 4.62% | US151020AM68 |
| CVS Health | 6.38% | 2050-04-01 | 4.25% | US126650DL16 |
| Solventum | 6.47% | 2054-04-30 | 5.90% | US83444MAS08 |
| Bayer AG | 6.83% | 2064-07-15 | 4.70% | USU07265AZ15 |
| HCA INC | 7.39% | 2095-11-15 | 7.50% | US197677AH07 |